Pocai A (2013) Action and therapeutic potential of oxyntomodulin
GLP-1 therapies are showing up in ophthalmic practice whether clinicians are ready for them or not, and the evidence on their ocular effects is as mixed as the patients taking them
Substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimers disease and dementia), cardiometabolic disorders, chronic kidney disease, COPD, pneumonia, liver failure, inflammatory bowel disease, liver cancer) all significantly declined
Customer Service: 3.5/5 Decent customer service
While GLP-1 shots are primarily used for diabetes management, they may also benefit specific individuals seeking to improve their health and well-being
When appetite is low, these portions feel manageablenot overwhelming